At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and
2019 factors influencing daily treatment choices in MS, especially practice guidelines …

Background Survey-based studies are frequently used to describe the economic impact of
multiple sclerosis (MS). However, there is no validated health resource survey available …

Background Natalizumab is a very effective treatment of multiple sclerosis (MS). Failure is
rare and should lead to consider some specific etiologies. The purpose of our study was to …

Multiple Sclerosis (MS) is the most prevalent chronic inflammatory disease of the central
nervous system, characterized by demyelination, axonal damage and progressive disability …

Background: This study aims to provide insight on the early application of high efficacy 2 nd
line DMDs from Bulgarian public payer perspective, referring to RWD. Methods: An Excel …

Onemocnění roztroušená skleróza je spjato se značnými dopady jak na kvalitu života
pacienta, tak na rozpočet plátce terapie. Terapie roztroušené sklerózy je realizována …

Multiple sclerosis (MS) is a chronic disease characterized by inflammatory demyelination
and neurodegeneration occurring either focally or diffusely throughout the white and grey …

Die deutschlandweite Prävalenz der multiplen Sklerose (MS) bei gesetzlich versicherten
Patienten auf Grundlage von Abrechnungsdaten des Zentralinstituts für die kassenärztlichen …

Multiple sclerosis (MS) is an inflammatory disease that leads to the destruction of myelin with
a consequent decrease in the speed of communication between the various areas of the …